Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Presented for research literature review only Biasin M et al
As of early 2026, active pharmaceutical MDLs include cases involving GLP-1 weight-loss drugs like Ozempic and Wegovy, Suboxone dental injury claims, and Depo-Provera brain tumor claims, among others
Key takeaways Zepbound is FDA approved for weight loss and obstructive sleep apnea
Lupins two semaglutide brand names, Semanext and Livarise, are part of its co-marketing arrangement with Zydus, while Zydus itself markets the same molecule under Semaglyn, Mashema, and Alterme
Injectable semaglutide and tirzepatide have a longer track record, with semaglutide now backed by cardiovascular outcome trial data showing reduced risk of major cardiac events
